Clinical Trials Directory

Trials / Completed

CompletedNCT06354556

Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects

Effect of Verapamil on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects: a Single Center, Open, Single Arm, and Fixed Sequence Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Shandong Suncadia Medicine Co., Ltd. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this phase Ⅰ study is to evaluate the effect of oral verapamil tablets on the pharmacokinetics of HRS-1893 in healthy subjects.

Conditions

Interventions

TypeNameDescription
DRUGHRS-1893 tabletHRS-1893 tablet single dose
DRUGVerapamil tabletVerapamil tablet 80 mg tid

Timeline

Start date
2024-04-26
Primary completion
2024-05-20
Completion
2024-05-20
First posted
2024-04-09
Last updated
2024-06-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06354556. Inclusion in this directory is not an endorsement.

Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects (NCT06354556) · Clinical Trials Directory